Cargando…
Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
The cohort was set up in order to analyze late effects in long-term testicular cancer survivors (TCS) and to contribute to the design of future follow-up programs addressing and potentially preventing late effects. Data for this cross-sectional study were collected between January 1, 2014, and Decem...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826343/ https://www.ncbi.nlm.nih.gov/pubmed/29515973 http://dx.doi.org/10.3389/fonc.2018.00037 |
_version_ | 1783302333613998080 |
---|---|
author | Kreiberg, Michael Bandak, Mikkel Lauritsen, Jakob Skøtt, Julie Wang Johansen, Nanna Borup Agerbaek, Mads Holm, Niels Vilstrup Johansen, Christoffer Daugaard, Gedske |
author_facet | Kreiberg, Michael Bandak, Mikkel Lauritsen, Jakob Skøtt, Julie Wang Johansen, Nanna Borup Agerbaek, Mads Holm, Niels Vilstrup Johansen, Christoffer Daugaard, Gedske |
author_sort | Kreiberg, Michael |
collection | PubMed |
description | The cohort was set up in order to analyze late effects in long-term testicular cancer survivors (TCS) and to contribute to the design of future follow-up programs addressing and potentially preventing late effects. Data for this cross-sectional study were collected between January 1, 2014, and December 31, 2016, among living Danish TCS and 60% agreed to participate in the cohort (N = 2,572). Mean time since testicular cancer (TC) diagnosis was 18 years (range 7–33) and mean age of participants was 53 years (range 25–95). Data consist of results of a questionnaire with patient reported outcomes which covers a broad range of items on late-effects. The study also included data obtained through linkages to Danish registries, a biobank, and clinical data from hospital files and pathology reports originating from the Danish Testicular Cancer Database (DaTeCa). The treatment during the observation period has been nearly the same for all stages of TC and is in agreement with today’s standard treatment, this allows for interesting analysis with a wide timespan. We have extensive data on non-responders and are able to validate our study findings. Data from a Danish reference population (N = 162,283) allow us to compare our findings with a Danish background population. The cohort can easily be extended to access more outcomes, or include new TCS. A limitation of the present study is the cross-sectional design and despite the large sample size, The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) lacks statistical power to study very rare late effects. Since it was voluntary to participate in the study we have some selection bias, for instance, we lack responders who were not in a paired relationship, but we would still argue that this cohort of TCSs is representative for TCSs in Denmark. COLLABORATION AND DATA ACCESS: Researches interested in collaboration with the DaTeCa-LATE study group please contact Professor Gedske Daugaard kirsten.gedske.daugaard@regionh.dk. |
format | Online Article Text |
id | pubmed-5826343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58263432018-03-07 Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) Kreiberg, Michael Bandak, Mikkel Lauritsen, Jakob Skøtt, Julie Wang Johansen, Nanna Borup Agerbaek, Mads Holm, Niels Vilstrup Johansen, Christoffer Daugaard, Gedske Front Oncol Oncology The cohort was set up in order to analyze late effects in long-term testicular cancer survivors (TCS) and to contribute to the design of future follow-up programs addressing and potentially preventing late effects. Data for this cross-sectional study were collected between January 1, 2014, and December 31, 2016, among living Danish TCS and 60% agreed to participate in the cohort (N = 2,572). Mean time since testicular cancer (TC) diagnosis was 18 years (range 7–33) and mean age of participants was 53 years (range 25–95). Data consist of results of a questionnaire with patient reported outcomes which covers a broad range of items on late-effects. The study also included data obtained through linkages to Danish registries, a biobank, and clinical data from hospital files and pathology reports originating from the Danish Testicular Cancer Database (DaTeCa). The treatment during the observation period has been nearly the same for all stages of TC and is in agreement with today’s standard treatment, this allows for interesting analysis with a wide timespan. We have extensive data on non-responders and are able to validate our study findings. Data from a Danish reference population (N = 162,283) allow us to compare our findings with a Danish background population. The cohort can easily be extended to access more outcomes, or include new TCS. A limitation of the present study is the cross-sectional design and despite the large sample size, The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) lacks statistical power to study very rare late effects. Since it was voluntary to participate in the study we have some selection bias, for instance, we lack responders who were not in a paired relationship, but we would still argue that this cohort of TCSs is representative for TCSs in Denmark. COLLABORATION AND DATA ACCESS: Researches interested in collaboration with the DaTeCa-LATE study group please contact Professor Gedske Daugaard kirsten.gedske.daugaard@regionh.dk. Frontiers Media S.A. 2018-02-21 /pmc/articles/PMC5826343/ /pubmed/29515973 http://dx.doi.org/10.3389/fonc.2018.00037 Text en Copyright © 2018 Kreiberg, Bandak, Lauritsen, Skøtt, Johansen, Agerbaek, Holm, Johansen and Daugaard. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Kreiberg, Michael Bandak, Mikkel Lauritsen, Jakob Skøtt, Julie Wang Johansen, Nanna Borup Agerbaek, Mads Holm, Niels Vilstrup Johansen, Christoffer Daugaard, Gedske Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) |
title | Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) |
title_full | Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) |
title_fullStr | Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) |
title_full_unstemmed | Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) |
title_short | Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) |
title_sort | cohort profile: the danish testicular cancer late treatment effects cohort (dateca-late) |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826343/ https://www.ncbi.nlm.nih.gov/pubmed/29515973 http://dx.doi.org/10.3389/fonc.2018.00037 |
work_keys_str_mv | AT kreibergmichael cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate AT bandakmikkel cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate AT lauritsenjakob cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate AT skøttjuliewang cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate AT johansennannaborup cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate AT agerbaekmads cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate AT holmnielsvilstrup cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate AT johansenchristoffer cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate AT daugaardgedske cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate |